Effects of long-term cryopreservation on peripheral blood progenitor cells

Cytotherapy

Volumn 14, Issue 10, 2012, Pages 1228-1234

  Vosganian, Gregory S ^a,b   Waalen, Jill ^b   Kim, Kevin ^c   Jhatakia, Sejal ^d   Schram, Ethan ^e   Lee, Tracey ^f   Riddell, Dan ^f   Mason, James R ^a,f  

^a SCRIPPS CLINIC   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c Kootenai Cancer Center   (United States)

^d KAISER PERMANENTE MEDICAL CENTER   (United States)

^e Martin o'Neil Cancer Center   (United States)

^f SCRIPPS GREEN HOSPITAL   (United States)

Author keywords

clonogenic assays; cryopreservation; hematopoietic stem cells; long term storage; peripheral blood progenitor cells; viability

Indexed keywords

AMYLOID; CD34 ANTIGEN; TRYPAN BLUE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLOOD STORAGE; BREAST CANCER; CELL ACTIVITY; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; FREEZING; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; LONG TERM EXPOSURE; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NEUROECTODERM TUMOR; OVARY CANCER; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SEX; SOLID TUMOR; THAWING;

EID: 84867657467     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2012.706707     Document Type: Article

References (23)

1. Kyle RA, Anderson KC, Greipp PR, Lazarus HM, Hurd DD, et al. Standard chemotherapy compared with highdose chemoradiotherapy for multiple myeloma: Final results of phase III US Intergroup Trial S9321. J Clin Oncol. 2006; 24: 929-36.
2. Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med. 1995; 333: 1540-5.
3. Stadtmauer EA. Multiple myeloma, 2004: One or two transplants? N Engl J Med. 2003; 349: 2551-3.
4. Einhorn LH, Williams SD, Chamness A, Brames MJ, Perkins SM, Abonour R. High-dose chemotherapy and stemcell rescue for metastatic germ-cell tumors. N Engl J Med. 2007; 357: 340-8.
5. Spurr EE, Wiggins NE, Marsden KA, Lowenthal RM, Ragg SJ. Cryopreserved human haematopoietic stem cells retain engraftment potential after extended (5-14 years) cryostorage. Cryobiology. 2002; 44: 210-7.
6. Donnenberg AD, Koch EK, Griffin DL, Stanczak HM, Kiss JE, Carlos TM, et al. Viability of cryopreserved BM progenitor cells stored for more than a decade. Cytotherapy. 2002; 4: 157-63.
7. Ayello J, Semidei-Pomales M, Preti R, Hesdorffer C, Reiss RF. Effects of long-term storage at -90 degrees C of bone marrow and PBPC on cell recovery, viability, and clonogenic potential. J Hematother. 1998; 7: 385-90.
8. Kobylka P, Ivanyi P, Breur-Vriesendorp BS. Preservation of immunological and colony-forming capacities of long-term (15 years) cryopreserved cord blood cells. Transplantation. 1998; 65: 1275-8.
9. Mugishima H, Harada K, Chin M, Suzuki T, Takagi K, Hayakawa S, et al. Effects of long-term cryopreservation on hematopoietic progenitor cells in umbilical cord blood. Bone Marrow Transplant. 1999; 23: 395-6.
10. Rybka W B, Mittermeyer K, Singer J W, Buckner C D, Thomas ED. Viability of human marrow after long-term cryopreservation. Cryobiology. 1980; 17: 424-8.
11. Lioznov M, Dellbrugger C, Sputtek A, Fehse B, Kroger N, Zander AR. Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM. Bone Marrow Transplant. 2008; 42: 121-8.
12. Martin-Henao GA, Torrico C, Azqueta C, Amill B, Querol S, Garcia J. Cryopreservation of hematopoietic progenitor cells from apheresis at high cell concentrations does not impair the hematopoietic recovery after transplantation. Transfusion. 2005; 45: 1917-24.
13. Akkok CA, Liseth K, Hervig T, Ryningen A, Bruserud O, Ersvaer E. Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators. Cytotherapy. 2009; 11: 749-60.
14. Fois E, 14. Desmartin M, Benhamida S, Xavier F, Vanneaux V, Rea D, et al. Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: Analysis of 952 autologous peripheral blood stem cell transplantations. Bone Marrow Transplant. 2007; 40: 831-5.
15. Milone G, Mercurio S, Strano A, Leotta S, Pinto V, Battiato K, et al. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on nonmononuclear cells in the infused suspension and patient age. Cyto therapy. 2007; 9: 348-55.
16. StemCell Technologies. Human Colony-Forming Cell Assays Using MethoCult. Version 3.0 edn. Vancouver, Canada: Stem- Cell Technologies; 2004. p. 1-40.
17. Barnett D, Janossy G, Lubenko A, Matutes E, Newland A, Reilly JT. Guideline for the fl ow cytometric enumeration of CD34 -haematopoietic stem cells. Prepared by the CD34 -haematopoietic stem cell working party. General Haematology Task Force of the British Committee for Standards in Haematology. Clin Lab Haematol. 1999; 21: 301-8.
18. Gratama J W, Kraan J, Keeney M, Sutherland D R, Granger V, Barnett D. Validation of the single-platform ISHAGE method for CD34( -) hematopoietic stem and progenitor cell enumeration in an international multicenter study. Cytotherapy. 2003; 5: 55-65.
19. Sutherland D R, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34 -cell determination by fl ow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996; 5: 213-26.
20. Sartor M, Antonenas V, Garvin F, Webb M, Bradstock KF. Recovery of viable CD34 -cells from cryopreserved hemopoietic progenitor cell products. Bone Marrow Transplant. 2005; 36: 199-204.
21. Abrahamsen JF, Wentzel-Larsen T, Bruserud O. Autologous transplantation: The viable transplanted CD34 -cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34 -cell dose measured pre-freeze in patients that receive more than 2 -10 6 CD34 -cells/kg. Cytotherapy. 2004; 6:356-62.
22. Amigo ML, d el Canizo MC, Caballero MD, Vazquez L, Corral M, Vidriales B, et al. Factors that infl uence long-term hematopoietic function following autologous stem cell transplantation. Bone Marrow Transplant. 1999; 24: 289-93.
23. Armitage S, Hargreaves R, Samson D, Brennan M, Kanfer E, Navarrete C. CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant. 1997; 20: 587-91.